ch.oddb.org
  
Fachinformation zu Levetiracetam DESITIN®:Desitin Pharma GmbH
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N03AX14 - LevetiracetamATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N03 - Antiepileptics
 
N03A - Antiepileptics

This group comprises preparations used in the treatment of epilepsy.
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

The DDDs for the antiepileptics are based on combination therapy.

N03AX - Other Antiepileptics

This group comprises antiepileptics, which cannot be classified in the preceding groups.
Fenfluramine indicated for the treatment of seizures associated with Dravet syndrome is classified here.
Gabapentin and pregabalin are classified in N02BF Gabapentinoids.

The DDDs for stiripentol and fenfluramine are based on the treatment of children with a bodyweight of 20 kg.

N03AX14 - Levetiracetam
StärkeAdm.RouteNote
 P 
 O